Clinical Trial Could Move the Needle in Traumatic Brain Injury
A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical trials for TBI. The study will compare the effects of off-label drugs that have been found to be effective in animal studies.
